| 1st Oct 2021 3:49 pm |
RNS |
Notice of AGM and Change of Director |
| 1st Oct 2021 12:36 pm |
RNS |
Total Voting Rights |
| 17th Sep 2021 2:35 pm |
RNS |
MaxCyte Set to Join Russell 2000® Index |
| 14th Sep 2021 7:00 am |
RNS |
Half-year Report |
| 14th Sep 2021 7:00 am |
RNS |
Filing of Form 10-Q |
| 2nd Sep 2021 2:26 pm |
RNS |
Notice of Results |
| 10th Aug 2021 7:00 am |
RNS |
Grant of Options |
| 9th Aug 2021 7:00 am |
RNS |
License with Sana Biotechnology |
| 5th Aug 2021 4:05 pm |
RNS |
Amendments to Bylaws |
| 3rd Aug 2021 3:51 pm |
RNS |
Closing of Offering |
| 2nd Aug 2021 7:00 am |
RNS |
Full Exercise of Over-Allotment Option |
| 30th Jul 2021 4:43 pm |
RNS |
Second Price Monitoring Extn |
| 30th Jul 2021 4:36 pm |
RNS |
Price Monitoring Extension |
| 30th Jul 2021 7:00 am |
RNS |
Pricing of Offering and Approval to List on Nasdaq |
| 26th Jul 2021 11:14 am |
RNS |
Launch of Offering and Application to List |
| 19th Jul 2021 12:30 pm |
RNS |
Termination of DI facility and transition to CDI |
| 12th Jul 2021 7:00 am |
RNS |
S-1 Financial information & Directorate Change |
| 12th Jul 2021 7:00 am |
RNS |
Public Filing of Registration Statement with SEC |
| 6th Jul 2021 5:36 pm |
RNS |
Result of Special Meeting |
| 16th Jun 2021 7:01 am |
RNS |
Publication of Annual Report and Accounts |
| 16th Jun 2021 7:00 am |
RNS |
Stockholder Circular and Notice of Special Meeting |
| 15th Jun 2021 7:00 am |
RNS |
Maxcyte Appoints Two New Non-Executive Directors |
| 2nd Jun 2021 9:18 am |
RNS |
Total Voting Rights |
| 25th May 2021 7:00 am |
RNS |
Signing of Strategic Platform Licence |
| 14th May 2021 7:00 am |
RNS |
Proposed Dual-Listing on Nasdaq |
| 13th May 2021 7:00 am |
RNS |
Consolidation of Trading Lines |
| 20th Apr 2021 7:00 am |
RNS |
Full Year Results |
| 15th Apr 2021 7:00 am |
RNS |
Notice of Full Year Results |
| 1st Apr 2021 7:00 am |
RNS |
Total Voting Rights |
| 11th Mar 2021 3:01 pm |
RNS |
Holding(s) in Company |
| 3rd Mar 2021 7:00 am |
RNS |
Total Voting Rights |
| 23rd Feb 2021 7:00 am |
RNS |
Participation in Upcoming Investor Conferences |
| 19th Feb 2021 7:00 am |
RNS |
Director Dealings and Issue of Equity |
| 17th Feb 2021 5:44 pm |
RNS |
Grant of Options |
| 15th Feb 2021 4:32 pm |
RNS |
Holding(s) in Company |
| 12th Feb 2021 1:59 pm |
RNS |
Holding(s) in Company |
| 8th Feb 2021 2:59 pm |
RNS |
Holding(s) in Company |
| 5th Feb 2021 9:01 am |
RNS |
Price Monitoring Extension |
| 4th Feb 2021 7:00 am |
RNS |
Director Dealings and Issue of Equity |
| 4th Feb 2021 7:00 am |
RNS |
CORRECTION: MaxCyte Announces £40m Subscription |
